Home/Filings/4/0001437749-25-023969
4//SEC Filing

Barrett Elizabeth A. 4

Accession 0001437749-25-023969

CIK 0001668243other

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 4:08 PM ET

Size

5.3 KB

Accession

0001437749-25-023969

Insider Transaction Report

Form 4
Period: 2025-07-28
Barrett Elizabeth A.
Chief Executive Officer
Transactions
  • Award

    Performance Stock Units

    2025-07-28+87,61587,615 total
    Ordinary Shares (87,615 underlying)
Footnotes (2)
  • [F1]Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]Represents performance stock units ("PSUs") granted to the reporting person on January 31, 2024 that were earned upon the achievement of a corporate milestone event. These PSUs remain subject to continued service through December 31, 2025, at which time they will vest and settle in ordinary shares.

Issuer

UroGen Pharma Ltd.

CIK 0001668243

Entity typeother

Related Parties

1
  • filerCIK 0001764157

Filing Metadata

Form type
4
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:08 PM ET
Size
5.3 KB